| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Association of in utero organophosphate pesticide exposure and fetal growth and length of gestation in an agricultural population.
|
Environ Health Perspect
|
2004
|
3.66
|
|
2
|
Large-scale gene-centric meta-analysis across 39 studies identifies type 2 diabetes loci.
|
Am J Hum Genet
|
2012
|
2.53
|
|
3
|
Association between in utero organophosphate pesticide exposure and abnormal reflexes in neonates.
|
Neurotoxicology
|
2005
|
2.49
|
|
4
|
Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with Height.
|
Am J Hum Genet
|
2010
|
2.15
|
|
5
|
Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease.
|
Arterioscler Thromb Vasc Biol
|
2003
|
2.01
|
|
6
|
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
Am J Hum Genet
|
2012
|
1.96
|
|
7
|
Vitamin C and E intake is associated with increased paraoxonase activity.
|
Arterioscler Thromb Vasc Biol
|
2002
|
1.93
|
|
8
|
Modulation of paraoxonase (PON1) activity.
|
Biochem Pharmacol
|
2005
|
1.80
|
|
9
|
Determination of paraoxonase 1 status without the use of toxic organophosphate substrates.
|
Circ Cardiovasc Genet
|
2008
|
1.76
|
|
10
|
Functional genomic of the paraoxonase (PON1) polymorphisms: effects on pesticide sensitivity, cardiovascular disease, and drug metabolism.
|
Annu Rev Med
|
2001
|
1.51
|
|
11
|
Measurement of paraoxonase (PON1) status as a potential biomarker of susceptibility to organophosphate toxicity.
|
Clin Chim Acta
|
2005
|
1.42
|
|
12
|
Expression of human paraoxonase (PON1) during development.
|
Pharmacogenetics
|
2003
|
1.40
|
|
13
|
Toxicity of chlorpyrifos and chlorpyrifos oxon in a transgenic mouse model of the human paraoxonase (PON1) Q192R polymorphism.
|
Pharmacogenet Genomics
|
2005
|
1.30
|
|
14
|
Loci influencing blood pressure identified using a cardiovascular gene-centric array.
|
Hum Mol Genet
|
2013
|
1.27
|
|
15
|
Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.
|
Biomarkers
|
2003
|
1.25
|
|
16
|
Engineered recombinant human paraoxonase 1 (rHuPON1) purified from Escherichia coli protects against organophosphate poisoning.
|
Proc Natl Acad Sci U S A
|
2008
|
1.24
|
|
17
|
Paraoxonase 1 (PON1) status and substrate hydrolysis.
|
Toxicol Appl Pharmacol
|
2008
|
1.21
|
|
18
|
Paraoxonase gene mutations in amyotrophic lateral sclerosis.
|
Ann Neurol
|
2010
|
1.20
|
|
19
|
Serum cholinesterase inhibition in relation to paraoxonase-1 (PON1) status among organophosphate-exposed agricultural pesticide handlers.
|
Environ Health Perspect
|
2009
|
1.14
|
|
20
|
Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.
|
Biochem Pharmacol
|
2010
|
1.14
|
|
21
|
Novel paraoxonase (PON1) nonsense and missense mutations predicted by functional genomic assay of PON1 status.
|
Pharmacogenetics
|
2003
|
1.14
|
|
22
|
Surface plasmon resonance detection using antibody-linked magnetic nanoparticles for analyte capture, purification, concentration, and signal amplification.
|
Anal Chem
|
2009
|
1.11
|
|
23
|
Detection of Staphylococcus aureus enterotoxin B at femtomolar levels with a miniature integrated two-channel surface plasmon resonance (SPR) sensor.
|
Biosens Bioelectron
|
2002
|
1.06
|
|
24
|
The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status.
|
J Lipid Res
|
2005
|
1.06
|
|
25
|
Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds.
|
Toxicol Appl Pharmacol
|
2009
|
1.06
|
|
26
|
Development of diagnostics in the search for an explanation of aerotoxic syndrome.
|
Anal Biochem
|
2010
|
1.04
|
|
27
|
Exposure to tri-o-cresyl phosphate detected in jet airplane passengers.
|
Toxicol Appl Pharmacol
|
2011
|
1.03
|
|
28
|
Portable 24-analyte surface plasmon resonance instruments for rapid, versatile biodetection.
|
Biosens Bioelectron
|
2007
|
1.02
|
|
29
|
Repeated developmental exposure of mice to chlorpyrifos oxon is associated with paraoxonase 1 (PON1)-modulated effects on cerebellar gene expression.
|
Toxicol Sci
|
2011
|
1.02
|
|
30
|
A portable surface plasmon resonance sensor system for real-time monitoring of small to large analytes.
|
J Ind Microbiol Biotechnol
|
2005
|
1.01
|
|
31
|
Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates.
|
J Toxicol Clin Toxicol
|
2003
|
1.00
|
|
32
|
Biomarkers of organophosphorus (OP) exposures in humans.
|
Neurotoxicology
|
2011
|
0.99
|
|
33
|
Determination of paraoxonase 1 status and genotypes at specific polymorphic sites.
|
Curr Protoc Toxicol
|
2004
|
0.99
|
|
34
|
Paraoxonase 1 status as a risk factor for disease or exposure.
|
Adv Exp Med Biol
|
2010
|
0.99
|
|
35
|
Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.
|
Toxicology
|
2012
|
0.99
|
|
36
|
Detection of cortisol in saliva with a flow-filtered, portable surface plasmon resonance biosensor system.
|
Anal Chem
|
2008
|
0.98
|
|
37
|
Immunosensor towards low-cost, rapid diagnosis of tuberculosis.
|
Lab Chip
|
2012
|
0.98
|
|
38
|
Identification and characterization of biomarkers of organophosphorus exposures in humans.
|
Adv Exp Med Biol
|
2010
|
0.94
|
|
39
|
Novel gene-by-environment interactions: APOB and NPC1L1 variants affect the relationship between dietary and total plasma cholesterol.
|
J Lipid Res
|
2013
|
0.94
|
|
40
|
Inflammatory response after influenza vaccination in men with and without carotid artery disease.
|
Arterioscler Thromb Vasc Biol
|
2006
|
0.93
|
|
41
|
Occupational determinants of serum cholinesterase inhibition among organophosphate-exposed agricultural pesticide handlers in Washington State.
|
Occup Environ Med
|
2009
|
0.92
|
|
42
|
TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease.
|
J Lipid Res
|
2006
|
0.92
|
|
43
|
Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.
|
Pharmacogenomics
|
2013
|
0.91
|
|
44
|
Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?
|
Toxicol Appl Pharmacol
|
2011
|
0.89
|
|
45
|
The relationship between Gulf War illness, brain N-acetylaspartate, and post-traumatic stress disorder.
|
Mil Med
|
2011
|
0.88
|
|
46
|
Dietary cholesterol increases paraoxonase 1 enzyme activity.
|
J Lipid Res
|
2012
|
0.88
|
|
47
|
Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease.
|
J Lipids
|
2012
|
0.87
|
|
48
|
Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL.
|
J Lipid Res
|
2012
|
0.83
|
|
49
|
Paraoxonase (PON1): from toxicology to cardiovascular medicine.
|
Acta Biomed
|
2005
|
0.83
|
|
50
|
Protein adducts as biomarkers of exposure to organophosphorus compounds.
|
Toxicology
|
2012
|
0.83
|
|
51
|
Modulation of paraoxonase 2 (PON2) in mouse brain by the polyphenol quercetin: a mechanism of neuroprotection?
|
Neurochem Res
|
2013
|
0.82
|
|
52
|
The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.
|
Adv Exp Med Biol
|
2010
|
0.80
|
|
53
|
Engineering human PON1 in an E. coli expression system.
|
Adv Exp Med Biol
|
2010
|
0.80
|
|
54
|
Dietary fatty acid intake is associated with paraoxonase 1 activity in a cohort-based analysis of 1,548 subjects.
|
Lipids Health Dis
|
2013
|
0.79
|
|
55
|
Biomarkers of sensitivity and exposure in Washington state pesticide handlers.
|
Adv Exp Med Biol
|
2010
|
0.79
|
|
56
|
Proteomic analysis of adducted butyrylcholinesterase for biomonitoring organophosphorus exposures.
|
Chem Biol Interact
|
2012
|
0.78
|
|
57
|
Neurobehavioral assessment of mice following repeated postnatal exposure to chlorpyrifos-oxon.
|
Neurotoxicol Teratol
|
2012
|
0.78
|
|
58
|
Identifying safer anti-wear triaryl phosphate additives for jet engine lubricants.
|
Chem Biol Interact
|
2012
|
0.75
|
|
59
|
Discussion and conclusions.
|
J Biochem Mol Toxicol
|
2005
|
0.75
|